AIDAN raises concerns over NPPA chairman's transfer

Demands that the NPPA be made into a statutory body to ensure the independence and integrity of the regulator

xffxcvxvx

Pratap Vikram Singh | March 1, 2018 | New Delhi


#AIDAN   #NPPA   #All India Drug Action Network   #National Pharmaceutical Pricing Authority  

All India Drug Action Network (AIDAN) has accused US-based multinational firms in healthcare for running a malicious campaign against National Pharmaceutical Pricing Authority (NPPA) and the transfer of its chairman Bhupendra Singh. The government move would adversely impact the NPPA's ongoing work against unethical profiteering by pharmaceutical companies, device makers and corporate hospitals, the AIDAN said in a statement.

According to a government notification issued on Wednesday, the appointments committee of the cabinet has transferred Singh to National Authority for Chemical Weapons Convention in the rank and pay of additional secretary.

"The NPPA under the governance of Injeti Srinivas (former chairman) and Singh showered tremendous leadership. Srinivas was transferred even before the completion of one year following the price regulation of critical cardiac and diabetes medicines through public interest of the DPCO. During his term, Singh has taken many positive steps to ensure affordability of medicines and medical devices that discomforted the industry," the AIDAN, a non-governmental organisation working towards increasing access and rational use of essential medicines, said. 

Notably, the NPPA undertook landmark price control of stents and knee implants. There was greater accountability to the public because of increased transparency and responsiveness to grievances of patients and the industry.

The NPPA, the AIDAN said, also saw unprecedented success in the courts with its stands vindicated by favourable judgments passed by the supreme court and high courts in most cases.

Of late, the NPPA took a proactive role in initiating monitoring of high margins charged by private hospitals in an effort to curb unethical profiteering.

"We fear that Singh's transfer in total disregard to the public interest is due to the pressure from the industry and corporate hospital lobby," the AIDAN said.

The pharmaceutical industry has long sought to undermine and weaken the NPPA in order to enable uninhibited profiteering and circumvention of the law. The recent price revise of coronary stents angered the US-based MNCs which ran a malicious campaign against the regulatory authority, the AIDAN said. 

"The final precipitating factor, we believe, was the report analysing bills of four patients and which exposed the gross overcharging and misconduct of private hospitals. In this same report, the NPPA appealed for policy intervention to correct the injustice towards patients as it had reached the limits of its mandate," the non-governmental organisation said.  

The AIDAN urged the government to reconsider its decision and allow Singh to complete his three year term at the NPPA. It also demanded that the NPPA be made into a statutory body along with fixed term periods for the chairman and leadership to ensure the independence and integrity of the regulator.

Comments

 

Other News

Learn from Mumbai model to manage oxygen supply: supreme court

Mumbai, once the epicentre of the pandemic in India, has emerged as a model for all others in mitigating the crisis. The supreme court on Wednesday said the central government should adopt and take lessons from the Mumbai model to manage liquid medical oxygen supply for Covid-19 patients in Delhi.

‘What do they know of history who only history know?’

A Functioning Anarchy? Essays For Ramachandra Guha Edited by Nandini Sundar and Srinath Raghavan Penguin Random House India / 392 pages / Rs 650 In a long and versatile career spanning thirty-five years, Ramachandra Guha has produced a vas

BMC commissioner urges Mumbaikars to come forward for testing

To take preventive steps early and save lives, BrihanMumbai municipal corporation (BMC) commissioner Iqbal Singh Chahal has urged citizens to come forward and get themselves tested.   Mumbai has seen a dip in Covid-19 cases in the last few days after an unprecedented increase in cases s

India records over 3 lakh recoveries, fresh cases down

India reported 3,68,147 new cases on Monday, a number lower than the 4 lakh-plus recorded in the weekend. Also, more than 29.16 crore Covid tests were conducted across the country. As many as 29,16,47,037 have been conducted as on date. India’s cumulative recoveries now stand

This Maharashtra district set up oxygen plants just ahead of the curve

Nandurbar, a tribal and hilly district in Maharashtra with a population of 20 lakh, is an unlikely contender for setting a precedent for the rest of India, but under the leadership of district collector Dr Rajendra Bharud, it took several measures to augment medical oxygen supply ahead of the second wave o

‘Mumbai cases down due to BMC commissioner’s good work’

RP Singh, national spokesperson, BJP, has praised Mumbai municipal commissioner Iqbal Singh Chahal for actively engaging with people and effectively handling Covid-19 and said that a good administrator will know how to navigate political influence and bring in good governance.   “

Visionary Talks with R P Singh, National Spokesperson, BJP



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter